Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...
Magnetic rocks with iron oxide concentrations act as natural chroniclers of Earth's past continental movements. Using small ...